Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle

M Gautel, DO Fürst, A Cocco, S Schiaffino - Circulation research, 1998 - Am Heart Assoc
M Gautel, DO Fürst, A Cocco, S Schiaffino
Circulation research, 1998Am Heart Assoc
Mutations in the gene for the cardiac isoform of myosin binding protein C (MyBP-C) have
been identified as the cause of chromosome 11–associated autosomal-dominant familial
hypertrophic cardiomyopathy (FHC). Most mutations produce a truncated polypeptide that
lacks the sarcomeric binding region. We have now investigated the expression pattern of the
cardiac and skeletal isoforms of cMyBP-C in mice and humans by in situ hybridization and
immunofluorescence microscopy using specific antibodies and probes. We demonstrate that …
Abstract
—Mutations in the gene for the cardiac isoform of myosin binding protein C (MyBP-C) have been identified as the cause of chromosome 11–associated autosomal-dominant familial hypertrophic cardiomyopathy (FHC). Most mutations produce a truncated polypeptide that lacks the sarcomeric binding region. We have now investigated the expression pattern of the cardiac and skeletal isoforms of cMyBP-C in mice and humans by in situ hybridization and immunofluorescence microscopy using specific antibodies and probes. We demonstrate that the cardiac isoform is expressed only in cardiac muscle throughout development. The slow and fast isoforms of MyBP-C remain specific for skeletal muscle, where they can be coexpressed. Immunological evidence also suggests that an embryonic isoform of MyBP-C precedes the expression of slow MyBP-C in developing skeletal muscle. This suggests that transcomplementation of MyBP-C isoforms is possible in skeletal but not cardiac muscle.
Am Heart Assoc